| SC 13D/A | 2024-04-25 | Lazar David E. | OPGEN INC | 2,490,861 | 16.8% | EDGAR |
| SC 13D/A | 2024-04-08 | Lazar David E. | OPGEN INC | 2,390,861 | 19.9% | EDGAR |
| SC 13D | 2024-04-01 | Lazar David E. | OPGEN INC | 2,390,861 | 19.9% | EDGAR |
| SC 13D/A | 2020-05-11 | Curetis N.V. in Liquidation | OPGEN INC | 0 | 0.0% | EDGAR |
| SC 13D/A | 2020-04-22 | Curetis N.V. in Liquidation | OPGEN INC | 1,711,555 | 11.6% | EDGAR |
| SC 13D | 2020-04-13 | Curetis N.V. in Liquidation | OPGEN INC | 2,028,208 | 13.8% | EDGAR |
| SC 13G/A | 2020-02-10 | CVI Investments, Inc. | OPGEN INC | 200,000 | 3.5% | EDGAR |
| SC 13G/A | 2020-01-06 | SABBY MANAGEMENT, LLC | OPGEN INC | 0 | 0.0% | EDGAR |
| SC 13D/A | 2019-11-27 | Merck Global Health Innovation Fund, LLC | OPGEN INC | 24,597 | 0.4% | EDGAR |
| SC 13G | 2019-11-01 | ARMISTICE CAPITAL, LLC | OPGEN INC | 172,631 | 5.0% | EDGAR |
| SC 13G | 2019-11-01 | CVI Investments, Inc. | OPGEN INC | 200,000 | 5.8% | EDGAR |
| SC 13G | 2019-03-27 | SABBY MANAGEMENT, LLC | OPGEN INC | 0 | 0.0% | EDGAR |
| SC 13D/A | 2019-02-28 | Versant Ventures III, LLC | OPGEN INC | 182,879 | 2.1% | EDGAR |
| SC 13D/A | 2019-02-14 | Merck Global Health Innovation Fund, LLC | OPGEN INC | 491,927 | 5.6% | EDGAR |
| SC 13G/A | 2019-02-14 | ARMISTICE CAPITAL, LLC | OPGEN INC | 454,067 | 5.0% | EDGAR |
| SC 13G/A | 2019-01-15 | Empery Asset Management, LP | OPGEN INC | 330,770 | 3.7% | EDGAR |
| SC 13G/A | 2019-01-03 | SABBY MANAGEMENT, LLC | OPGEN INC | 198,688 | 2.3% | EDGAR |
| SC 13D/A | 2018-08-09 | Merck Global Health Innovation Fund, LLC | OPGEN INC | 491,927 | 7.8% | EDGAR |
| SC 13G | 2018-02-16 | SABBY MANAGEMENT, LLC | OPGEN INC | 31,049 | 0.6% | EDGAR |
| SC 13G | 2018-02-12 | ARMISTICE CAPITAL, LLC | OPGEN INC | 358,505 | 6.9% | EDGAR |